Outlook Therapeutics drops 80% on CRL for BLA for wet AMD asset (NASDAQ:OTLK)
The US FDA has issued a Complete Response Letter to Outlook Therapeutics (OTLK) for its resubmitted Biologics License Application for ...
Thursday, January 1, 2026
Tag: BLA
- Trending
- Comments
- Latest
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.